Dr. Ito is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1200 E Michigan Avenue
Suite 655
Lansing, MI 48912Phone+1 517-267-2460Fax+1 517-267-2462- Is this information wrong?
Education & Training
- Brigham and Women's HospitalResidency, Surgery, 2004 - 2007
- Graduate School of Medicine and Faculty of Medicine, The University of TokyoClass of 1997
Certifications & Licensure
- MI State Medical License 2010 - 2017
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow American College of Surgeons
Publications & Presentations
PubMed
- Editorial Expression of Concern: Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness.Mark S Duxbury, Hiromichi Ito, Eric Benoit, Michael J Zinner, Stanley W Ashley, Edward E Whang> ;Oncogene. 2023 Aug 1
- Retraction Note: RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine.Mark S Duxbury, Hiromichi Ito, Michael J Zinner, Stanley W Ashley, Edward E Whang> ;Oncogene. 2023 Mar 1
- Retraction notice to Glucose transporter-1 gene expression is associated with pancreatic cancer invasiveness and MMP-2 activity [Surgery -September 2004, Pages 548-556].Hiromichi Ito, Mark Duxbury, Michael J Zinner, Stanley W Ashley, Edward E Whang> ;Surgery. 2023 Apr 1
- Join now to see all
Press Mentions
- A Large Hypervascular Mesenteric MassFebruary 10th, 2021
Professional Memberships
- Member
Hospital Affiliations
- Sparrow HospitalLansing, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: